Loading…

Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease

Vascular liver disease (VLD) presents special challenges in the diagnosis, surveillance, and treatment of hepatocellular carcinoma (HCC). HCC arising in the setting of vascular liver disease is often thought to be due to elevated hepatic arterial blood flow, rather than progressive fibrosis from chr...

Full description

Saved in:
Bibliographic Details
Published in:The Kaohsiung journal of medical sciences 2021-05, Vol.37 (5), p.355-360
Main Authors: Prasad, Debi, Nguyen, Mindie H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vascular liver disease (VLD) presents special challenges in the diagnosis, surveillance, and treatment of hepatocellular carcinoma (HCC). HCC arising in the setting of vascular liver disease is often thought to be due to elevated hepatic arterial blood flow, rather than progressive fibrosis from chronic inflammation as with other chronic liver conditions such as viral hepatitis, autoimmune, and metabolic liver diseases. Vascular alteration inherent in VLD often impedes HCC non‐invasive diagnosis and loco‐regional treatment that depend on vascular properties found in typical liver environment. Benign and pre‐malignant liver nodules such as focal nodular hyperplasia and hepatocellular adenoma are also more common in certain VLDs, further adding to surveillance and diagnostic challenges. In this synopsis, we aimed to review available literature on the epidemiology, surveillance, diagnosis, and management of HCC in patients with VLD and specifically Budd–Chiari syndrome, congenital porto‐systemic shunts, Fontan‐associated liver disease, hereditary hemorrhagic telangiectasia.
ISSN:1607-551X
2410-8650
DOI:10.1002/kjm2.12368